• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同型半胱氨酸、脂蛋白(a)与纤维蛋白原:慢性肾病心血管并发症的代谢风险因素。

Homocysteine, lipoprotein(a) and fibrinogen: metabolic risk factors for cardiovascular complications of chronic renal disease.

作者信息

Kronenberg F

机构信息

Institute of Medical Biology and Human Genetics, University of Innsbruck, Austria.

出版信息

Curr Opin Nephrol Hypertens. 1998 May;7(3):271-8. doi: 10.1097/00041552-199805000-00006.

DOI:10.1097/00041552-199805000-00006
PMID:9617557
Abstract

High plasma concentrations of homocysteine, lipoprotein(a) and fibrinogen are accompanied by an increased risk for cardiovascular complications in the general population. All three parameters are markedly elevated in patients with renal disease, a group with a high prevalence and incidence of cardiovascular complications. This review discusses these parameters in such patients in relation to the occurrence of atherosclerotic complications.

摘要

在普通人群中,高血浆同型半胱氨酸、脂蛋白(a)和纤维蛋白原浓度与心血管并发症风险增加相关。在肾病患者中,这三个参数均显著升高,该群体心血管并发症的患病率和发病率都很高。这篇综述讨论了此类患者中这些参数与动脉粥样硬化并发症发生情况的关系。

相似文献

1
Homocysteine, lipoprotein(a) and fibrinogen: metabolic risk factors for cardiovascular complications of chronic renal disease.同型半胱氨酸、脂蛋白(a)与纤维蛋白原:慢性肾病心血管并发症的代谢风险因素。
Curr Opin Nephrol Hypertens. 1998 May;7(3):271-8. doi: 10.1097/00041552-199805000-00006.
2
Homocysteine, fibrinogen, and lipoprotein(a) levels are simultaneously reduced in patients with chronic renal failure treated with folic acid, pyridoxine, and cyanocobalamin.接受叶酸、吡哆醇和氰钴胺治疗的慢性肾衰竭患者,其同型半胱氨酸、纤维蛋白原和脂蛋白(a)水平会同时降低。
Metabolism. 2001 Feb;50(2):131-4. doi: 10.1053/meta.2001.20174.
3
The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease.慢性肾病患者中冠心病非传统危险因素的患病率。
Ann Intern Med. 2004 Jan 6;140(1):9-17. doi: 10.7326/0003-4819-140-1-200401060-00006.
4
Summaries for patients. Associations of newer cardiac risk factors with chronic kidney disease.患者摘要。新型心脏危险因素与慢性肾脏病的关联。
Ann Intern Med. 2004 Jan 6;140(1):I26. doi: 10.7326/0003-4819-140-1-200401060-00002.
5
Importance of homocysteine, lipoprotein (a) and non-classical cardiovascular risk factors (fibrinogen and advanced glycation end-products) for atherogenesis in uraemic patients.同型半胱氨酸、脂蛋白(a)及非传统心血管危险因素(纤维蛋白原和晚期糖基化终产物)在尿毒症患者动脉粥样硬化形成中的重要性。
Nephrol Dial Transplant. 2000;15 Suppl 5:81-91. doi: 10.1093/ndt/15.suppl_5.81.
6
Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive protein.慢性肾脏病中的潜在心血管危险因素:晚期糖基化终末产物、总同型半胱氨酸及其代谢产物,以及C反应蛋白。
Kidney Int. 2004 Jul;66(1):338-47. doi: 10.1111/j.1523-1755.2004.00736.x.
7
Lipoprotein(a) in renal patients: is it a key factor in the high cardiovascular mortality?肾病患者中的脂蛋白(a):它是心血管高死亡率的关键因素吗?
Nephrol Dial Transplant. 1994;9(8):1066-8. doi: 10.1093/ndt/9.8.1066.
8
Homocysteine or renal impairment: which is the real cardiovascular risk factor?同型半胱氨酸还是肾功能损害:哪一个才是真正的心血管危险因素?
Arterioscler Thromb Vasc Biol. 2008 Jun;28(6):1158-64. doi: 10.1161/ATVBAHA.108.162743. Epub 2008 Mar 20.
9
Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: a matched case-control study.维持性透析患者的高同型半胱氨酸血症、高纤维蛋白原血症和脂蛋白(a)升高:一项配对病例对照研究。
Atherosclerosis. 1996 Aug 23;125(1):91-101. doi: 10.1016/0021-9150(96)05865-0.
10
Atherosclerosis and Folic Acid Supplementation Trial: untangling the web of cardiac risk in chronic kidney disease.动脉粥样硬化与叶酸补充试验:理清慢性肾脏病中心脏病风险的复杂关系。
Nephrology (Carlton). 2004 Jun;9(3):112-3. doi: 10.1111/j.1440-1797.2004.00253.x.

引用本文的文献

1
Metabolic syndrome, chronic kidney disease, and cardiovascular disease: a dynamic and life-threatening triad.代谢综合征、慢性肾脏病和心血管疾病:一个动态且危及生命的三联征。
Cardiol Res Pract. 2011 Feb 20;2011:747861. doi: 10.4061/2011/747861.